Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Entrada Therapeutics Q4 EPS $(0.79) Beats $(0.83) Estimate

Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(0.83) by 4.82 percent. This is a 11.24 percent increase over losses of $(0.89) per share
byBenzinga Newsdesk
March 6, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Entrada Therapeutics (NASDAQ:TRDA) reported quarterly losses of $(0.79) per share which beat the analyst consensus estimate of $(0.83) by 4.82 percent. This is a 11.24 percent increase over losses of $(0.89) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts